Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

A Study of Irritable Bowel Syndrome and Stress on Female College Students in Korea

국내 여자 대학생에서 과민성 장증후군과 스트레스에 관한 연구

  • Shin, Jieun (Graduate School of Clinical Pharmacy, Sookmyung Women's University) ;
  • Kim, Kwang Joon (College of Pharmacy, Woosuk University) ;
  • Bang, Joon Seok (College of Pharmacy, Sookmyung Women's University)
  • 신지은 (숙명여자대학교 임상약학대학원) ;
  • 김광준 (우석대학교 약학대학) ;
  • 방준석 (숙명여자대학교 약학대학)
  • Received : 2019.04.26
  • Accepted : 2019.07.24
  • Published : 2019.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The purpose of this study was to provide a database for making better decisions of the treatment of the irritable bowel syndrome (IBS) patient, and for improving the recognition of IBS in the Korean society. Methods: The survey was conducted on 174 female college students in Korea from January 2017 to January 2018. Out of the total students surveyed, 160 questionnaires were analyzed after excluding 14 uncompleted questionnaires. Results: Based on the survey, the prevalence of IBS among female college students in Korea was found to be 13.8%. Statistically, the results proved that there were significant differences in the stress levels between the students with IBS and non-IBS diagnosed by ROME IV criteria. Students with IBS had higher stress levels than students without the ailment. Conclusions: Based on this study, stress management related treatment should be actively considered. Furthermore, it is necessary to develop more efficient and updated guidelines for the treatment of IBS and new patient care programs.

Keywords

References

  1. Choi MK, Chung HK, Chang BH, et al. Estimation of disease burden of irritable bowel syndrome. Korea Institute of Health and Welfare Research Report 2011;1-208.
  2. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. American College of Gastroenterology Task Force on Irritable Bowel Syndrome. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104(Suppl 1):S1-S35.
  3. El-Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171-85. https://doi.org/10.1046/j.1365-2036.2002.01290.x
  4. Kim MJ. A study of IBS and sleep quality of student majoring in dental hygienist in some areas. J Dent Hyg 2014;14(1):22-8.
  5. Kim HJ, Cha RR, Kim HJ. Understanding of ROME IV criteria: Irritable bowel syndrome and functional diarrhea. Korean J Med 2017;92(4):366-71. https://doi.org/10.3904/kjm.2017.92.4.366
  6. Kasper D, Fauci A, Hauser S, et al. In; Harrison's Principles of Internal Medicine 19e (Vol. 1 & Vol. 2). McGraw-Hill Education. 2015:269-84.
  7. Kwan AC, Bao TN, Chakkaphak S, et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003;18(7):796-802. https://doi.org/10.1046/j.1440-1746.2003.03081.x
  8. Ford AC, Brandt LJ, Young C, et al. Efficacy of 5-$HT_3$ antagonists and 5-$HT_4$ agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009;104:1831-43. https://doi.org/10.1038/ajg.2009.223
  9. Matsueda K, Harasawa S, Hongo M, et al. A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrheapredominant irritable bowel syndrome. Digestion 2008;77:225-35. https://doi.org/10.1159/000150632
  10. Matsueda K, Harasawa S, Hongo M, et al. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol 2008;43:1202-11. https://doi.org/10.1080/00365520802240255
  11. Mayer EA, Naliboff BD, Chang L, et al. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001;280(4):G519-24. https://doi.org/10.1152/ajpgi.2001.280.4.G519
  12. Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978;2:653-4. https://doi.org/10.1136/bmj.2.6138.653
  13. Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016;150:1257-61. https://doi.org/10.1053/j.gastro.2016.03.035
  14. PanelNow Solution. Available from https://m.blog.naver.com/PostView.nhn?blogId=panelnow&logNo=221019985620&proxyReferer=http%3A%2F%2Fwww.google.com%2Furl%3Fsa%3Dt%26rct%3Dj%26q%3D%26esrc%3Ds%26source%3Dweb%26cd%3D6%26ved%3D2ahUKEwiopYj8prrhAhVPyYsBHV0AD6sQFjAFegQIABAB%26url%3Dhttp%253A%252F%252Fm.blog.naver.com%252Fpanelnow%252F221019985620%26usg%3DAOvVaw0kI4k0aAam4f4cpKJXQnQ0. Accessed November 15, 2017.
  15. Yim JH, Bae JM, Choi SS, et al. The validity of modified Koreantranslated BEPSI (Brief Encounter Psychosocial Instrument) as instrument of stress measurement in outpatient clinic. J Korean Acad Fam Med 1996;17:42-53.
  16. Park HJ. Treatment guidelines of irritable bowel syndrome. Korean J Neurogastroenterol Motil 2005;11:36-43.
  17. Park JH, Byeon JS, Shin WG, et al. Diagnosis of irritable bowel syndrome: a systematic review. Korean J Gastroenterol 2010;55:308-15. https://doi.org/10.4166/kjg.2010.55.5.308
  18. Kwon JG, Park KS, Park JH, et al. Guidelines for the Treatment of Irritable Bowel Syndrome. Korean J Gastroenterol 2011;57(2):82-99. https://doi.org/10.4166/kjg.2011.57.2.82
  19. Jung D, Park H, Kim M. A study of irritable bowel syndrome, self-esteem, depression, and physical health in female university students. Korean J Women Health Nurs 2008;14(4):306-13. https://doi.org/10.4069/kjwhn.2008.14.4.306
  20. Blanchard EB, Keefer L, Galovski TE, et al. Gender differences in psychological distress among patients with irritable bowel syndrome. J Psychosom Res 2001;50(5):271-5. https://doi.org/10.1016/S0022-3999(01)00207-0
  21. Shiotani A, Miyanishi T, Takahashi T. Sex differences in irritable bowel syndrome in Japanese university students. J Gastroenterol 2006;41(6):562-8. https://doi.org/10.1007/s00535-006-1805-2
  22. Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011;140(3):761-5. https://doi.org/10.1053/j.gastro.2011.01.032
  23. Lee S, Suh M. Exploring Subjective Stress, Sleep and Diurnal Variation of Salivary Cortisol in Korean Female Adults. J Korean Biol Nurs Sci 2016;18(1):9-16. https://doi.org/10.7586/jkbns.2016.18.1.9
  24. Lee KE. Health Care Resource Use and Patients' Satisfaction for Irritable Bowel Syndrome. Ewha Womans University Graduate School, Master's Thesis, 2015.
  25. Han JU, Cho A, Choe YK, et al. The prevalence of Irritable Bowel Syndrome-type symptoms and the relationship with stress in medical, dental, and nursing students. Korean J Health Promot Dis Pre 2005;5(1):1-6.
  26. Locke III GR, Zinsmeister AR, Talley NJ, et al. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000;95(1):157-65. https://doi.org/10.1111/j.1572-0241.2000.01678.x

Cited by

  1. 서울·경기지역 일부 중장년 성인의 주관적 건강인지, 식습관 및 건강 관련 습관에 관한 연구 vol.27, pp.3, 2019, https://doi.org/10.14373/jkda.2021.27.3.162
  2. Influence of Irritable Bowel Syndrome on Stress and Depressive Symptoms in Nurses: The Korea Nurses’ Health Study vol.18, pp.23, 2019, https://doi.org/10.3390/ijerph182312324